NCT01913431View on ClinicalTrials.gov

Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 12, 2013

Primary Completion Date

November 6, 2015

Study Completion Date

November 6, 2015

Conditions
HBeAg-Positive Chronic Hepatitis B
Interventions
DRUG

Baracle Tab.®

DRUG

Baraclude Tab.®

Trial Locations (1)

138-736

Asan Medical Center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT01913431 - Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B | Biotech Hunter | Biotech Hunter